Incorporating Incretin-Based Therapies Into Clinical Practice: Differences Between Glucagon-Like Peptide 1 Receptor Agonists and Dipeptidyl Peptidase 4 Inhibitors
Keywords: دیپپتیدیل پپتیداز 4; BP; blood pressure; CHD; coronary heart disease; CI; confidence interval; CVD; cardiovascular disease; DM; diabetes mellitus; DPP-4; dipeptidyl peptidase 4; DURATION; Diabetes therapy Utilization: Researching changes in A1c, weight and other factors Throu